Healthcare
fromPatently-O
3 months agoRepublican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding Dispute
The ongoing demand for GLP-1s has resulted in a significant shortage and legal dispute regarding alternative compounding pharmacies.